Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Effectiveness of Novel Amino Acid-enriched Supplement Beverages to Determine Post-ingestion Glycemia, Insulinemia, Aminoacidemia, and Whole-body Protein Synthesis Rates in Adults Prescribed GLP-1 RA Drugs

NCT07595575 is registered in ClinicalTrials.gov with Nutraceutical Innovations LLC as lead sponsor.

NCT NCT07595575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Effectiveness of Novel Amino Acid-enriched Supplement Beverages to Determine Post-ingestion Glycemia, Insulinemia, Aminoacidemia, and Whole-body Protein Synthesis Rates in Adults Prescribed GLP-1 RA Drugs
Lead sponsor
Nutraceutical Innovations LLC
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 1, 2026
Enrollment
8 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the whole-body protein synthesis response to protein with amino acid or amino acids